Research Paper Volume 14, Issue 2 pp 826—844

A new signature based on alternative polyadenylation for prognostic prediction and therapeutic responses in low-grade glioma


Figure 2. The key features were identified using LASSO regression. (A) Selection of the optimal parameter (lambda) via 5 times cross–validation. (B) LASSO coefficient profiles of the top 20 prognosis-related APA events.